Amylyx Pharmaceuticals Announces Pricing of $175 Million Underwritten Public Offering of Common Stock

Core Viewpoint - Amylyx Pharmaceuticals, Inc. has announced a public offering of 17,500,000 shares of its common stock at a price of $10.00 per share, with an additional option for underwriters to purchase up to 2,625,000 shares [1] Company Summary - The public offering consists entirely of shares offered by Amylyx Pharmaceuticals [1] - The company has granted underwriters a 30-day option to purchase additional shares at the public offering price [1]